Polycystic ovary syndrome (PCOS) diagnostic market comprises solutions and services for diagnosis of PCOS condition in women. PCOS is one of the common endocrine disorders among women of reproductive age. Commonly used diagnostic tools for PCOS include ultrasound scanning, blood tests and genetic testing. These diagnostic tools help determine if a woman's symptoms, such as irregular periods or excess hair growth, are caused by PCOS. Rise in women population suffering from PCOS and increasing awareness about early diagnosis are fueling growth of the market.
The Global PCOS Diagnostic Market is estimated to be valued at US$ 3.9 Bn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the PCOS Diagnostic market are F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, SRL Diagnostics.
The adoption of point-of-care diagnostic tools for PCOS Diagnostic Market Demand provides convenient access to diagnostic services to patients. This drives demand for home use diagnostic kits and devices.
Rising awareness about PCOS and availability of advanced diagnostic techniques are encouraging more women globally to opt for early diagnosis. This will support expansion of key players into emerging markets.
Market drivers
Increasing preference for non-invasive diagnostic techniques especially among young women is a key driver. Technology developments facilitating non-invasive tests such as ultrasound scans, saliva & urine-based tests are witnessing high demand. Another major market driver is rising healthcare spending in developing countries improving access to diagnosis. This opens growth avenues for market players to tap developing markets.
PEST Analysis
Political: The government regulations support the growth of in vitro diagnostics industry which positively impacts the PCOS diagnostic market.
Economic: Rising healthcare spending and increasing disposable income levels allow more women to opt for advanced diagnostic tests for conditions like PCOS.
Social: Growing health awareness about conditions like PCOS and availability of more diagnostic options encourage women to timely detect the disorder.
Technological: Advancements in diagnostic tools like ultrasound devices, hormonal testing kits aid early and accurate diagnosis of PCOS. Development of non-invasive diagnostic techniques would further drive the market.
The North American region holds the major share of the PCOS Diagnostic Market owing to high healthcare spending, rising prevalence of lifestyle diseases and presence of key market players. Growing awareness among youth about health and wellness supplements the regional market growth.
The Asia Pacific region is expected to witness the fastest growth over the forecast period owing to rising medical tourism, improving healthcare infrastructure and increasing healthcare spending in emerging countries like India and China. Growing disposal incomes allow more women to opt for advanced diagnostic tests, driving the APAC PCOS diagnostic market.
Get more insights on PCOS Diagnostic Market
About Author:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )
Comments